60 related articles for article (PubMed ID: 19563826)
1. Therapeutic potential of dithiolethiones for hepatic diseases.
Brooks SC; Brooks JS; Lee WH; Lee MG; Kim SG
Pharmacol Ther; 2009 Oct; 124(1):31-43. PubMed ID: 19563826
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway.
Bae EJ; Yang YM; Kim JW; Kim SG
Hepatology; 2007 Sep; 46(3):730-9. PubMed ID: 17668885
[TBL] [Abstract][Full Text] [Related]
3. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones.
Hwahng SH; Ki SH; Bae EJ; Kim HE; Kim SG
Hepatology; 2009 Jun; 49(6):1913-25. PubMed ID: 19378344
[TBL] [Abstract][Full Text] [Related]
4. Oltipraz promotion of liver regeneration after partial hepatectomy: The role of PI3-kinase-dependent C/EBPbeta and cyclin E regulation.
Cho IJ; Sung DK; Kang KW; Kim SG
Arch Pharm Res; 2009 Apr; 32(4):625-35. PubMed ID: 19407981
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of arachidonic acid and iron-induced mitochondrial dysfunction and apoptosis by oltipraz and novel 1,2-dithiole-3-thione congeners.
Shin SM; Kim SG
Mol Pharmacol; 2009 Jan; 75(1):242-53. PubMed ID: 18945820
[TBL] [Abstract][Full Text] [Related]
6. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
Lee SJ; Kim SG
Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of hyperosmotic impairment of insulin signaling by a novel class of 1,2-dithiole-3-thiones through the inhibition of S6K1 activation.
Bae EJ; Yang YM; Kim SG
Mol Pharmacol; 2008 May; 73(5):1502-12. PubMed ID: 18252807
[TBL] [Abstract][Full Text] [Related]
8. This month in APR.
Kang KW
Arch Pharm Res; 2009 Apr; 32(4):463-4. PubMed ID: 19407961
[No Abstract] [Full Text] [Related]
9. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance.
Zick Y
Sci STKE; 2005 Jan; 2005(268):pe4. PubMed ID: 15671481
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR
Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609
[TBL] [Abstract][Full Text] [Related]
11. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant and mitochondrial protective effects of oxidized metabolites of oltipraz.
Choi SH; Kim YM; Lee JM; Kim SG
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):213-24. PubMed ID: 20095791
[TBL] [Abstract][Full Text] [Related]
13. Nutrient sensing in the mTOR/S6K1 signalling pathway.
Gulati P; Thomas G
Biochem Soc Trans; 2007 Apr; 35(Pt 2):236-8. PubMed ID: 17371247
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase.
Tang X; Wang L; Proud CG; Downes CP
Biochem J; 2003 Aug; 374(Pt 1):137-43. PubMed ID: 12747804
[TBL] [Abstract][Full Text] [Related]
15. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats.
Hu LY; Sun ZG; Wen YM; Cheng GZ; Wang SL; Zhao HB; Zhang XR
Neuroscience; 2010 Sep; 169(3):1046-62. PubMed ID: 20678995
[TBL] [Abstract][Full Text] [Related]
16. Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages.
Yang CS; Song CH; Lee JS; Jung SB; Oh JH; Park J; Kim HJ; Park JK; Paik TH; Jo EK
Cell Microbiol; 2006 Jul; 8(7):1158-71. PubMed ID: 16819968
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.
Davidson NE; Egner PA; Kensler TW
Cancer Res; 1990 Apr; 50(8):2251-5. PubMed ID: 2317812
[TBL] [Abstract][Full Text] [Related]
18. Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein-mediated stellate cell inactivation.
Kang KW; Kim YG; Cho MK; Bae SK; Kim CW; Lee MG; Kim SG
FASEB J; 2002 Dec; 16(14):1988-90. PubMed ID: 12397085
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific regulation of S6K1 by insulin in chickens divergently selected for growth.
Duchêne S; Audouin E; Berri C; Dupont J; Tesseraud S
Gen Comp Endocrinol; 2008 Mar; 156(1):190-8. PubMed ID: 18237733
[TBL] [Abstract][Full Text] [Related]
20. hvps34, an ancient player, enters a growing game: mTOR Complex1/S6K1 signaling.
Nobukuni T; Kozma SC; Thomas G
Curr Opin Cell Biol; 2007 Apr; 19(2):135-41. PubMed ID: 17321123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
